26 results
424B5
GLUE
Monte Rosa Therapeutics Inc
16 May 24
Prospectus supplement for primary offering
4:04pm
about our executive compensation arrangements;
not being required to hold advisory votes on executive compensation or to obtain stockholder approval … disclosure about our executive compensation arrangements;
not being required to hold advisory votes on executive compensation or to obtain stockholder
424B5
GLUE
Monte Rosa Therapeutics Inc
15 May 24
Prospectus supplement for primary offering
4:04pm
of Financial Condition and Results of Operations” disclosure;
reduced disclosure about our executive compensation arrangements;
not being required to hold … advisory votes on executive compensation or to obtain stockholder approval of any golden parachute arrangements not previously approved
424B5
x996ba ky76
26 Oct 23
Prospectus supplement for primary offering
4:55pm
PRE 14A
qe9nv2wxa8v82oudq
12 Apr 23
Preliminary proxy
4:07pm
S-3
qtxy9gdequsgv3y6ik
1 Jul 22
Shelf registration
5:01pm
DEFA14A
acd1u
8 Jun 22
Additional proxy soliciting materials
4:11pm
DEF 14A
bl3zw
27 Apr 22
Definitive proxy
4:10pm
10-K
qy50mbx hp
29 Mar 22
Annual report
4:15pm
10-Q
ronqpwqokr4wmb9sg1y
12 Aug 21
Quarterly report
4:22pm